Virios Therapeutics (NASDAQ:VIRI) Trading Down 7.3% – Time to Sell?

Virios Therapeutics, Inc. (NASDAQ:VIRI)’s share price was down 7.3% during mid-day trading on Tuesday . The stock traded as low as $2.77 and last traded at $2.78. Approximately 39,565 shares were traded during mid-day trading, a decline of 96% from the average daily volume of 1,049,645 shares. The stock had previously closed at $3.00.

Virios Therapeutics Price Performance

The company has a market cap of $53.54 million, a price-to-earnings ratio of -10.30 and a beta of 1.58. The stock has a 50-day moving average price of $2.99 and a 200 day moving average price of $4.66.

Virios Therapeutics Company Profile

Virios Therapeutics, Inc is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of targeted therapies for fibrotic diseases. The company leverages its proprietary small-molecule platform to identify and advance compounds designed to modulate key pathways involved in scar formation and tissue repair. By concentrating on conditions with high unmet medical need, Virios aims to improve patient outcomes through more effective and safer treatment options.

The company’s lead development candidate, VTI-1002, is an oral small molecule inhibitor in clinical trials for the prevention and treatment of hypertrophic scars and keloids.